Cognition Therapeutics Inc (NASDAQ:CGTX)’s traded shares stood at 41.45 million during the last session, with the company’s beta value hitting 1.01. At the close of trading, the stock’s price was $0.50, to imply a decrease of -4.18% or -$0.02 in intraday trading. The CGTX share’s 52-week high remains $2.95, putting it -490.0% down since that peak but still an impressive 32.0% since price per share fell to its 52-week low of $0.34.
Analysts have given a consensus recommendation of Buy for Cognition Therapeutics Inc (CGTX), translating to a mean rating of 1.00. Of 3 analyst(s) looking at the stock, 0 analyst(s) give CGTX a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 3 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.15.
Cognition Therapeutics Inc (NASDAQ:CGTX) trade information
After registering a -4.18% downside in the last session, Cognition Therapeutics Inc (CGTX) has traded red over the past five days. The 5-day price performance for the stock is -21.43%, and -30.28% over 30 days. With these gigs, the year-to-date price performance is -29.42%.
Cognition Therapeutics Inc (CGTX) estimates and forecasts
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -21.09% for the past 5-year period. While 2025 is set for a 4.46% return in earnings, projections for the next 5 years are at 9.38% annually.
CGTX Dividends
Cognition Therapeutics Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Cognition Therapeutics Inc (NASDAQ:CGTX)’s Major holders
The next major institution holding the largest number of shares is AWM INVESTMENT COMPANY, INC. with 0.65 million shares, or about 1.6224% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $1.08 million.
